| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |